PNC Financial Services Group’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$735K Sell
26,750
-1,845
-6% -$49K ﹤0.01% 1543
2026
Q1
$767K Sell
28,595
-1,238
-4% -$37.1K ﹤0.01% 1428
2025
Q4
$919K Buy
29,833
+3,917
+15% +$122K ﹤0.01% 1304
2025
Q3
$795K Buy
25,916
+7,294
+39% +$178K ﹤0.01% 1362
2025
Q2
$385K Sell
18,622
-81,907
-81% -$1.68M ﹤0.01% 1743
2025
Q1
$1.97M Buy
100,529
+26,027
+35% +$546K ﹤0.01% 914
2024
Q4
$1.55M Sell
74,502
-18,776
-20% -$413K ﹤0.01% 997
2024
Q3
$2.27M Sell
93,278
-4,774
-5% -$128K ﹤0.01% 876
2024
Q2
$2.46M Sell
98,052
-9,318
-9% -$264K ﹤0.01% 837
2024
Q1
$3.21M Sell
107,370
-57,817
-35% -$1.7M ﹤0.01% 766
2023
Q4
$5.26M Buy
165,187
+8,463
+5% +$266K ﹤0.01% 629
2023
Q3
$5.53M Buy
156,724
+3,611
+2% +$138K ﹤0.01% 600
2023
Q2
$5.82M Buy
153,113
+5,898
+4% +$235K 0.01% 600
2023
Q1
$5.56M Sell
147,215
-6,861
-4% -$264K ﹤0.01% 613
2022
Q4
$6.53M Sell
154,076
-32,834
-18% -$1.35M 0.01% 570
2022
Q3
$6.01M Sell
186,910
-18,639
-9% -$654K 0.01% 576
2022
Q2
$6.68M Buy
205,549
+808
+0.4% +$26.2K 0.01% 570
2022
Q1
$7.41M Sell
204,741
-47,678
-19% -$1.64M 0.01% 589
2021
Q4
$9.98M Sell
252,419
-6,177
-2% -$258K 0.01% 531
2021
Q3
$11.3M Sell
258,596
-1,897
-0.7% -$85.2K 0.01% 486
2021
Q2
$10.6M Buy
260,493
+83,895
+48% +$3.24M 0.01% 501
2021
Q1
$5.8M Sell
176,598
-75,079
-30% -$2.82M 0.01% 599
2020
Q4
$10.2M Buy
251,677
+9,238
+4% +$345K 0.01% 485
2020
Q3
$8.88M Buy
242,439
+88,878
+58% +$3.21M 0.01% 482
2020
Q2
$5.21M Buy
153,561
+142,364
+1,271% +$3.88M 0.01% 573
2020
Q1
$237K Buy
11,197
+265
+2% +$5.91K ﹤0.01% 1720
2019
Q4
$245K Buy
10,932
+810
+8% +$17.7K ﹤0.01% 1934
2019
Q3
$205K Buy
+10,122
New +$199K ﹤0.01% 2117

Other funds holding GMAB

PNC Financial Services Group's GMAB Position: Q2 2026 in Review

PNC Financial Services Group reduced its Genmab (GMAB) stake by 6.5% in Q2 2026, selling an estimated $49K and leaving 26,750 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

PNC Financial Services Group first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $11.3M in Q3 2021. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • PNC Financial Services Group held 26,750 shares of Genmab worth $735K as of Q2 2026.
  • PNC Financial Services Group sold 1,845 Genmab shares in Q2 2026, an estimated $49K.
  • Genmab made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1543 holding.
  • PNC Financial Services Group first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • PNC Financial Services Group's Genmab position peaked at $11.3M in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.